Caricamento...
Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients
OBJECTIVE: Therapeutic drug monitoring (TDM) enables individualization in the treatment to optimize clinical benefit and minimize drugs' side effects. Critically ill septic patients represent a challenge for antimicrobial treatment because of pathophysiological impact of sepsis on pharmacokinet...
Salvato in:
| Pubblicato in: | J Basic Clin Pharm |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Medknow Publications & Media Pvt Ltd
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910469/ https://ncbi.nlm.nih.gov/pubmed/27330257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-0105.183260 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|